The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow. The spray, called Spravato, is now the first-ever standalone therapy for treatment-resistant depression, which is when trying at least two standard treatments does little to nothing to improve depression symptoms in a patient. Previously, Spravato was cleared in the U.S. to use together with an oral antidepress ...

Peoples Bancorp (PEBO) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $1.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 9.33%. A quarter ago, it was expected that this financial services and products company would post earnings of $0.83 per share when it actually produced earnings of $0.89, delivering a surprise of 7.23%.Over the la ...

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and certain of its senior executives for potential violations of the federal securities laws. If you invested in BioAge, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/bioage-labs-inc. Investors have until March 10, 2025, to ask the Court to be appointed to lead the case ...

公司表现 - 高盛集团（NYSE: GS）股票在过去一年中上涨超过60% 并且技术分析显示其仍有进一步上涨空间 [1] 分析师背景 - 分析师为专注于美国市场的加拿大投资者 主要关注科技和金融领域 拥有金融学学士学位 并以优异成绩毕业 同时是Beta Gamma Sigma国际商业荣誉学会终身会员 [1] 投资理念 - 分析师秉持"以一流方式经营一流业务"的理念 致力于在Seeking Alpha平台上提供高质量的技术分析文章 核心价值包括卓越 诚信 透明和尊重 [1]

国际在线专稿：中国海关总署日前发布的数据显示，2024年，中国外贸规模再创历史新高，货物贸易进 出口总值43.85万亿元人民币，同比增长5%。中国在全球经济复苏疲软的大背景下逆势增长，突出表现 吸引全球目光，赢得国际社会广泛赞誉。美国《欧亚评论》网站刊发学者伊姆兰·哈立德的署名文章， 文章深度聚焦中国2024年外贸发展成果，并从多个维度分析这一积极势头对世界经济的深远影响。 文章称，相关数据揭示了中国外贸增长强劲程度远超预期，西方评论员纷纷表示惊叹。中国外贸成就为 全球贸易伙伴观察中国提供了窗口。在国际局势紧张、各国贸易政策频繁调整的环境下，外界得以充分 了解中国市场晴雨表。尽管仍有部分怀疑论者叫嚣，但中国与世界持续紧密的贸易往来昭示着务实主义 的胜利，中国创纪录的进出口贸易额实实在在地说明了当前中国经济的韧性与强适应性。 文章强调，2024年中国外贸成就远远超越单纯的统计数据增长，更体现在数量、质量和科技水平显著 的"三重提升"上。文章举例，在高科技含量产品领域，中国电动汽车、3D打印机和工业机器人出口分 别大幅增长13.1%、32.8%和45.2%，凸显中国正积极转向尖端产业，全球科技领导者地位不断增强； ...

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc. Investors have until February 18, 2025, to a ...

It’s no exaggeration to say that First Watch (NASDAQ: FWRG ) is the only one of its kind. This fast-growing restaurant chain is arguably the only U.S.-based family dining chainI'm an Equity Analyst and Accountant specializing in restaurant stocks, with a strong foundation in Business Administration and Accounting, complemented by an MBA in Forensic Accounting and Controllership. As the founder of Goulart's Restaurant Stocks, I lead a company focused on analyzing restaurant stocks in the U.S. market. Our cov ...

Valneva SE (VALN) , a specialty vaccine company, recently reported positive Phase 3 - VLA1553-321 data in adolescents (12 to 17 years old) for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ. For investors’ note, IXCHIQ is the world’s first and only licensed chikungunya vaccine available to address this significant unmet medical need. The trial data supports and strengthens the pivotal data previously reported for adolescents in the United States, Europe and Canada. Data from this trial are also e ...

公司业绩表现 - 公司最新季度每股收益为1.22美元 超出市场预期的1.15美元 同比增长6.09% [1] - 公司最新季度营收为5853万美元 超出市场预期的1.86% 同比增长2.78% [2] - 过去四个季度中 公司三次超出每股收益预期 四次超出营收预期 [2] 市场表现与预期 - 公司股价年初至今下跌0.6% 同期标普500指数上涨2% [3] - 当前市场对公司未来季度每股收益预期为1.08美元 营收预期为5670万美元 [7] - 当前市场对公司本财年每股收益预期为4.50美元 营收预期为2.335亿美元 [7] 行业表现 - 公司所属的中西部银行行业在Zacks行业排名中位列前14% [8] - Zacks排名前50%的行业表现优于后50% 优势超过2:1 [8] - 同行业的Park National公司预计最新季度每股收益为2.27美元 同比增长13.5% [9] - Park National公司预计最新季度营收为1.2449亿美元 同比增长12.6% [9]

Nixxy Commences Private Offering of up to $50 million of Bitcoin Secured Convertible Notes ...